March 20, 2015
Daiichi Sankyo and AstraZeneca (AZ) of the UK announced on March 19 that they have entered an agreement to copromote AZ’s Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), in the US market. AZ plans to launch the product in...read more